ロード中...
Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
Background. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 Canadian patients with Clostridium difficile infection (CDI), based on data from 2 randomized, clinical trials. Methods. Patients received fidaxomicin or vancomycin 1. Patients were assessed for clinical response...
保存先:
| 出版年: | Can J Infect Dis Med Microbiol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4904592/ https://ncbi.nlm.nih.gov/pubmed/27366179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/8048757 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|